EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A study on bile from patients with recurrent common bile duct stones and cholangiocarcinoma following ERCP using non-targeted metabolomics

Yong-Kai Kuang, Yu-Tong Wu, Dan-Dan Wang, Gao-Feng Lu

Frontiers in Medicine · 16.04.2026 · 13

DOI: 10.3389/fmed.2026.1770095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 16.04.2026. Verfasst von Yong-Kai Kuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to analyze bile samples from patients with common bile duct stones and cholangiocarcinoma using non-targeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics, in order to identify disease-associated differential metabolites and metabolic pathways, and to establish metabolite-based models for predicting bile duct stone recurrence and facilitating diagnosis of cholangiocarcinoma.

Methods

Bile samples and clinical data were collected from 50 patients who underwent ERCP with nasobiliary drainage tube placement at the Second Affiliated Hospital of Zhengzhou University between January and June 2025. Among them, 20 cases were primary choledocholithiasis (PDS), 15 cases were recurrent choledocholithiasis (RDS) (with ≥6 months since previous choledocholithiasis detection), and 15 with cholangiocarcinoma (CCA). LC-MS was used to detect small-molecule metabolites in bile. Principal Component Analysis (PCA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) were performed on the results. Differential metabolites were identified using metabolomics databases. The screening criteria were set at p < 0.05 and fold change <0.67 or >1.50, combined with variable importance projection >1.00. Pathway enrichment analysis was performed. Based on the selected differential metabolites, predictive models for common bile duct stone recurrence and cholangiocarcinoma were established, and preliminary model evaluation was conducted using receiver operating characteristic (ROC) curves.

Results

LC-MS identified a total of 174 metabolites with secondary match names. Based on screening criteria, 32 differentially expressed metabolites were selected, including 17 between the PDS and RDS groups, 8 between the PDS and CCA groups, and 7 between the RDS and CCA groups. Significant enrichment was observed in the unsaturated fatty acid, amino acid, and sphingolipid metabolic pathways. Among the 17 differential metabolites in the PDS and RDS groups, four metabolites with consistent trend changes and AUC values exceeding 0.7 were selected to construct a common bile duct stone recurrence model. The area under the ROC curve reached 0.92, with a sensitivity of 86.7% and a specificity of 90.2%. Additionally, in both the stone group and cholangiocarcinoma group, the diagnostic efficacy of the novel tumor marker combination of arachidonic acid and dimethyl phosphate surpassed that of the traditional tumor marker combination of CA19-9 and CEA.

Conclusion

Recurrent common bile duct stones and cholangiocarcinoma patients exhibit distinct alterations in bile metabolic profiles. Specific combinations of bile metabolites hold promise as potential biomarkers for diagnosing recurrent common bile duct stones and cholangiocarcinoma.

Schlagwörter

Stichwörter der Autor:innen

bilecholangiocarcinomacommon bile duct stonesnon-targeted metabolomicsrecurrence

Autor:innen und Institutionen

  • Department of Gastroenterology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

Zitieren

APA

Kuang, Y. K., Wu, Y. T., Wang, D. D., & Lu, G. F. (2026). A study on bile from patients with recurrent common bile duct stones and cholangiocarcinoma following ERCP using non-targeted metabolomics. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1770095

Vancouver

Kuang YK, Wu YT, Wang DD, Lu GF. A study on bile from patients with recurrent common bile duct stones and cholangiocarcinoma following ERCP using non-targeted metabolomics. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1770095

BibTeX
@article{Kuang2026,
  author = {Kuang, Yong-Kai and Wu, Yu-Tong and Wang, Dan-Dan and Lu, Gao-Feng},
  title = {A study on bile from patients with recurrent common bile duct stones and cholangiocarcinoma following ERCP using non-targeted metabolomics},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1770095}
}
Kostenlos starten →